Showing 7,941 - 7,960 results of 18,571 for search 'significant ((((((a decrease) OR (greater decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.55s Refine Results
  1. 7941

    Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin‑Dependent Kinase‑Like 5 Deficiency Disorder by Sheridan M. Hoy (4897468)

    Published 2024
    “…While somnolence and sedation are related to the dose of ganaxolone, they appear early in treatment and may decrease with continued therapy. Thus, although current evidence is somewhat limited, adjunctive ganaxolone could be a valuable therapeutic option for patients aged 2–17 years with epileptic seizures associated with CDD.…”
  2. 7942
  3. 7943

    Physical properties of porous media. by Yingguo Wang (21094364)

    Published 2025
    “…The loess interlayer retained water due to its low permeability, while the sandy interlayer caused water retention in the overlying clay soil as a result of its low matric potential. Based on the simulation outcomes, it is recommended that a 10 cm thick loess interlayer at a depth of 40 cm in sandy soil enhances upper soil moisture availability for vegetation, whereas a 10 cm thick sandy interlayer at the same depth in loess soil improves soil permeability. …”
  4. 7944
  5. 7945
  6. 7946

    Critical period EB odorant experience via Or42a neurons specifically elevates VM7 serotonin signaling. by Vanessa Kay Miller (19775496)

    Published 2024
    “…Two-way ANOVA with Tukey’s multiple comparisons show a significant increase in serotonin (<i>n</i> = 12/condition, <i>p</i> = 7.13 × 10<sup>−5</sup>) and a significant decrease in VM7 innervation (<i>n</i> = 12/condition, <i>p</i> = 4.78 × 10<sup>−10</sup>) with EB experience. …”
  7. 7947

    Table 1_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

    Published 2025
    “…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”
  8. 7948

    Table 5_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

    Published 2025
    “…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”
  9. 7949

    Table 4_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

    Published 2025
    “…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”
  10. 7950

    Table 2_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

    Published 2025
    “…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”
  11. 7951

    Table 3_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

    Published 2025
    “…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”
  12. 7952

    Image 1_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.tif by Xiaoqin Lu (3121482)

    Published 2025
    “…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”
  13. 7953

    Image 2_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.tif by Xiaoqin Lu (3121482)

    Published 2025
    “…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”
  14. 7954

    Multimorbidity and health related quality of life in midlife – a longitudinal study from Northern Finland Birth Cohort 1966 by Oili Junttila (21337262)

    Published 2025
    “…Furthermore, the more diseases the patient had at the age of 31, the more mean 15D-Scores decreased when having more new emerging diseases at the age of 46.…”
  15. 7955

    Table 1_Effects of icariin as a feed additive on the reproductive function in bucks (Capra hircus).docx by Fang-e Zhao (20140809)

    Published 2024
    “…However, the serum concentration of GnRH in the ICA group initially increased, followed by a subsequent decrease (p < 0.05). The hypothalamic concentrations of dopamine (DA) and 5-hydroxytryptamine (5-HT) were significantly higher in the ICA group compared to the control group (p < 0.01). …”
  16. 7956
  17. 7957

    Domains of NoCs. by Gizachew Tadele Tiruneh (8407686)

    Published 2025
    “…The interrupted time series analysis indicated that the rate of ANC 8+ visits was 29.8% per month higher than expected without the NoCs strategy (Coef: 2.39; p-value < 0.01) and an 18.4% increase in obstetric complications managed (Coef: 1.71; p-value = 0.050), with a 43% overall increase. Perinatal mortality decreased by 34%, from 31.3 to 20.1 per 1,000 births [t-test: 2.12; p-value: 0.040)].…”
  18. 7958

    SNAP-25 (1-197) binds to syntaxin-1A, and the interaction is enhanced by Ser187 phosphorylation. by Dilara Koc (22431017)

    Published 2025
    “…<b>(C and D)</b> PMA treatment further decreases neurotransmitter release when a low level of SNAP-25 cleavage is present. …”
  19. 7959

    [A] Histopathological images of pancreas, liver, kidney, and heart tissues from the studied rat groups, stained with H&E. by Mohamed Lotfy (18599184)

    Published 2025
    “…The values are presented as mean ± SEM. <sup>#</sup> Indicates significant difference (P ≤ 0.05) between the untreated diabetic group and the control group. * Indicates a significant difference (P ≤ 0.05) between the C. lancifolius-treated or crocin-treated diabetic group and the untreated diabetic group. …”
  20. 7960

    Image 1_Use of a specialized peptide-based enteral formula containing medium-chain triglycerides for enteral tube feeding in children with cerebral palsy and previous tube feeding... by Aydan Kansu (13015700)

    Published 2025
    “…Objective<p>Use of peptide-based formulas supplemented with medium chain triglycerides (MCTs) is considered a beneficial strategy to decrease the tube-feeding associated gastrointestinal tolerance. …”